EL
EXAS

Essex LLC’s Exact Sciences EXAS Stock Holding History

Essex LLC’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,900
Closed -$295K – 182
2025
Q4 		$295K Buy
+2,900
New +$233K 0.05% 147
2024
Q2 		– Sell
-2,900
Closed -$200K – 157
2024
Q1 		$200K Hold
2,900
– – 0.05% 151
2023
Q4 		$215K Buy
+2,900
New +$190K 0.05% 145
2023
Q3 		– Sell
-2,900
Closed -$272K – 162
2023
Q2 		$272K Buy
+2,900
New +$226K 0.08% 124
2022
Q2 		– Sell
-2,900
Closed -$203K – 158
2022
Q1 		$203K Hold
2,900
– – 0.06% 161
2021
Q4 		$226K Hold
2,900
– – 0.06% 161
2021
Q3 		$277K Buy
+2,900
New +$306K 0.08% 150

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Essex LLC's EXAS Position: Q1 2026 in Review

Essex LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,900 shares — an estimated $295K sold.

Essex LLC first reported a position in EXAS in Q3 2021 and held it in 7 quarters. The position peaked at $295K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Essex LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Essex LLC sold 2,900 Exact Sciences shares in Q1 2026, an estimated $295K.
  • Essex LLC first reported a position in Exact Sciences in Q3 2021 and held it in 7 quarters.
  • Essex LLC's Exact Sciences position peaked at $295K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Essex LLC's 13F filing for Q1 2026, filed 24 Apr 2026.